Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06199570 · ClinicalTrials.gov registry record · NA

Support for Cancer Patients Awaiting News

A NA study of Lung Cancer, sponsored by Hackensack Meridian Health.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06199570 is a NA study of Lung Cancer that is actively recruiting participants, run by Hackensack Meridian Health. The registered enrollment target is 60 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06199570, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Hackensack Meridian Health.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This is a behavioral trial study to pilot test a stress management intervention for people with cancer who are undergoing routine cancer scans. The study will involve two pilot testing phases. Initial feasibility will be determined in an Open Trial phase, to inform any needed revisions to the intervention and/or protocol prior to a Pilot Randomized Controlled Trial phase. The Open Trial phase is an unblinded, single-site, single-arm open trial (n=10). The Pilot randomized clinical trial (RCT) phase is an unblinded, single-site, feasibility pilot randomized controlled trial (n=50).

Conditions Studied

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL Adapted Stress Management Program

Study Locations (1)

New Jersey

  • Amanda Khoudary - Hackensack

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-05-01
Est. Completion 2026-12-30
Phase NA

Sponsor

Hackensack Meridian Health

90 total trials

What the Registry Record Tells You About NCT06199570

The ClinicalTrials.gov registry entry for NCT06199570 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT06199570 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06199570 about?

NCT06199570 is a clinical study titled "Support for Cancer Patients Awaiting News". This is a behavioral trial study to pilot test a stress management intervention for people with cancer who are undergoing routine cancer scans. The study will involve two pilot testing phases. Initial feasibility will be determined in an Open Trial phase, to inform any needed revisions to the interv...

What is the current status of trial NCT06199570?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-05-01. Estimated completion is 2026-12-30.

What conditions does trial NCT06199570 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT06199570?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Adapted Stress Management Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06199570?

This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06199570 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.